Primum Health, Inc.

Based in the US, Primum Health, Inc. provides a specialized online platform connecting oncologists with expert oncology consultants for informed treatment decisions in complex cases. Primum Health, Inc. , founded in 2021, operates from Columbus, US, offering an online service for oncologists to consult with specialists.

The company has undergone strategic developments since inception, including a recent funding round to enhance its service offerings. The latest funding round was a SEED round closed on September 25, 2025, co-led by FCA Venture Partners and North Coast Ventures, positioning the company as a target for investment. The founder's history is not disclosed. Erica Conroy is leading the firm as CEO as of 2025.

Primum offers an innovative online platform that connects oncologists with specialized oncology experts for curbside consultations. The core functionality of the Primum app allows healthcare providers to pose questions related to complex oncology cases, thereby facilitating informed decision-making regarding treatment options. This service is designed to support oncologists in navigating the rapidly evolving landscape of cancer therapies, including novel drugs and treatment protocols, and is accessible to healthcare professionals across the United States. Primum generates revenue through a subscription-based model designed for oncology providers.

Clients subscribe to access the platform, enabling them to consult with national oncology specialists and receive tailored advice for their specific needs. The pricing structure includes different subscription tiers, allowing for varying levels of access to expert consultations and resources. Transactions occur directly between Primum and its users, promoting an efficient B2B service that emphasizes collaboration in cancer care. Following the recent SEED funding round concluded on September 25, 2025, Primum Health, Inc.

aims to accelerate its growth by expanding its physician network and scaling its team. The funds will also be directed towards investing in advanced tools and analytics to enhance value for physicians, patients, and partners. The company plans to introduce new products to strengthen its platform offerings and is targeting expansion into additional markets, although specific regions have not been disclosed.